Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Healthcare Industry News Technology Industry News What Erik Todd’s appointment reveals about Swan EndoSurgical’s strategy for advanced GI robotics Swan EndoSurgical appoints former Stryker executive Erik Todd as CEO to accelerate flexible surgical robotics. See how this move reshapes GI intervention strategy. byPallavi MadhirajuDecember 3, 2025